Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Ultramarine carries a story stretching back to the age of pharaohs and frescoes. Artisans once relied on ground lapis lazuli, hauling blue stone from Afghan mountains, turning rarity into luxury with paint that rivaled gold in price. Synthetic ultramarine changed the game in the 19th century, pulling blue out of exclusive temples and monasteries and putting it onto far more affordable palettes. That shift was not just about cheaper paint, but about opening up blue’s possibilities to people beyond a wealthy elite. The synthetic version entered the pharmaceutical world by blending that rich color history with the industry’s demands for consistency and purity. In my time around old school paintmakers and formulation chemists, the phrase “ultramarine” floats up like a badge for overcoming resource limits with ingenuity.
Ultramarine BP EP USP pharma grade stands for a highly refined blue pigment crafted to meet the British, European, and United States Pharmacopeia standards. Unlike bulk-grade pigments, pharma grade ultramarine undergoes extra purification to remove trace metals and other contaminants that could spell trouble in sensitive drug applications. The product lands as a fine blue powder, popular for coloring oral tablets, capsules, and sometimes topical creams. Its chemical backbone sits on a sodium aluminosilicate structure, trapping sulfur-based radicals inside, which lend that distinct blue punch without running risks of bleeding or fading commonly seen in other colors. Pharmaceutical companies lean on this grade because trust in a colorant’s safety cannot be left to chance, especially when patients’ health is in the mix.
Handling pharma grade ultramarine feels like handling history in powdered form. The material pours as a soft, deep blue powder, with a pigment particle size measured down to a few microns. It carries no taste and has almost no solubility in water or organic solvents. This insolubility protects finished drug tablets from color migration or unpredictable fading during storage. Chemically, the structure forms with a sodium aluminosilicate skeleton, baked with elemental sulfur at high temperatures to nail down the signature blue. Resistance to acids and alkalis means the color stays true, whether dosed in acidic stomach environments or shelf-stable over the counter. Pharmacopeial standards strictly limit the allowable levels of lead, arsenic, and other heavy metals, with testing that drills down into single parts per million. That deep blue hue owes everything to trapped polysulfide anions—not a filler dye but a pigment born in a fiery kiln.
Official labels on pharma grade ultramarine must disclose a full breakdown of chemical composition, batch number, expiration date, and heavy metal content. I once spent a week examining pigment shipments for a generics manufacturer; every bag arrived with certificates of analysis outlining particle size distribution, iron and lead test results, and verification it passes the latest BP, EP, and USP requirements. Specifications demand the powder appear dry, homogeneous, and free of lumps. Pharmacopeial monographs lay out chemical identification routines, including solubility trials and infrared spectra that fingerprint the pigment’s signature sulfur bonds. The tiniest hint of impurity has brought entire batches under scrutiny, especially where regulatory inspections dig deep into color additive origins. Meeting this bar requires discipline from sourcing raw materials right through to the last micron-sized grain sealed in the drum.
Making synthetic ultramarine takes both chemistry and grit—temperatures rise above 700°C in ceramic kilns where kaolin, sodium carbonate, sulfur, and sometimes charcoal react. The solid-state process pushes air out to create a reducing atmosphere, coaxing the right shades from sulfur radicals. After firing, the blue mass cools, then gets milled into a fine powder and washed several times with water and sometimes mild acids. Each wash pulls out byproducts that can cloud compliance with pharmacopeial purity standards. In my time consulting for pigment labs, several batches failed for residual iron or excess soluble salts, reinforcing just how much skill rides on post-synthesis purification. Achieving true pharma grade purity is as much about patience as the original chemical blueprint.
Ultramarine’s sturdy aluminosilicate framework keeps it inert against most conditions, immune to acid hydrolysis at levels found in medications. That resistance lets it stand up to formulation processes without fading or reacting with active pharmaceutical ingredients. The main chemical challenge comes from environmental sulfur cycling, where overexposure to acidic conditions can leach out sulfur and dull the blue over time. Some pigment houses have developed proprietary processes to modify the outer layers of particles, adding a thin silicate or titanium dioxide coating, further boosting chemical resistance. Modifications often aim for stability and ease of dispersion in tablet binders rather than changing the color.
The same blue pigment can hide behind a row of names: Ultramarine Blue, Pigment Blue 29, CI 77007, Lazurite synthetic, and Sodium aluminosilicate sulphide. Product names depend on the producer, but in the pharmaceutical space, labels stick strictly to CI numbers or regulatory names to avoid confusion. I have seen the same colorant referenced differently in European, American, and Asian regulatory filings, sometimes leading to headaches in multi-market product registrations. Sticking to pharmacopeial designations cuts through the ambiguity, especially when clear traceability matters most.
Safety around ultramarine blue always focuses on the most sensitive populations. Regulatory agencies demand evidence that the pigment will not leach toxic metals, promote allergic responses, or degrade under normal storage. Hazards associated with inhalation center on fine particulate dust, so manufacturing lines bring in dust containment and personal protective equipment. Clean-in-place systems and air monitoring ensure particles do not spread between workspaces, which is especially crucial in pharmaceutical factories running parallel processes. Material safety data sheets stress minimal toxicity by oral and dermal exposure, but repeated batch testing remains the real guardrail. I have met regulatory auditors whose entire day revolved around pigment trace metal audits; the lessons always drive home the fact that safety isn’t a formality, but the bedrock of public trust.
Ultramarine blue’s reach spreads mainly through oral solid dosage forms—tablets and capsules benefit from its stable color and non-reactivity. Many generic, branded medicines and even nutraceuticals incorporate ultramarine for reliable blue color that withstands compaction, heat, and time on shelves. Some topical creams also use it, provided the product will not reach open wounds or mucous membranes. I’ve watched color matching sessions at pharma plants where teams grind out unaffected blues over months-long stability tests. Ultramarine blue’s non-staining nature keeps it out of the bloodstream; the pigment passes through the digestive system unchanged, another nod to its trustworthiness. Its presence in foods and easier regulatory clearance has encouraged some consumer health brands to use this pigment for chewables and even children’s formulations where visual cues support dosing accuracy.
Future proofs for ultramarine come from research across interface science and drug delivery. Developers look at nano-structuring particle surfaces to boost pigment dispersal in low-water systems or to enhance the masking of bitter taste in chewables. Another line of inquiry investigates potential antioxidant properties attributed to certain forms of encapsulated sulfur in ultramarine, exploring whether these properties translate into measurable benefits for drugs susceptible to oxidation. Researchers in excipient science ask if modifications could allow pairing ultramarine with more sensitive or complex drug actives without any interaction. From my discussions with formulation scientists, every ounce of the pigment’s improvement revolves around balancing brighter hues with lower particle aggregation, always ensuring that any tweak still meets strict pharmacopeial standards.
Toxicology teams place every colorant, including ultramarine blue, under a microscope. Published studies, including work by the Joint FAO/WHO Expert Committee on Food Additives, highlight that ultramarine, free from harmful heavy metals and impurities, sails through acute and chronic toxicity screens. Long-term animal tests demonstrate no bioaccumulation or carcinogenicity, and rare cases of allergic reactions typically stem from contamination in lower-grade pigments. Regulatory reviews point out that all safety hinges upon maintaining purity at every manufacturing step. I recall batch audits stalling an entire production run over a microgram of extraneous iron—an example showing zero tolerance for impurity, especially where young children or immunocompromised users rely on the final medicine. Trust in its safety profile rests on constant vigilance.
Innovation in pharma grade ultramarine moves toward higher purity, better dispersion, and new formulation technologies that push the boundaries of what a safe pigment can do. Pharmaceutical companies seek out blue pigments that remain bright and stable in advanced drug delivery systems—think orodispersible films, fast-melt tablets, and long-acting depot implants. AI-driven screening of raw materials and rapid batch analysis promises faster, more reliable detection of trace contaminants. As regulatory agencies harmonize global standards, colorants will face even sharper scrutiny crossing borders, driving producers to invest in ever more robust purification and documentation processes. Ultramarine blue keeps showing an ability to adapt, bridging eras from ancient lapis lazuli to tomorrow’s precision medicine. Its story continues not as a relic of the past, but as an ingredient scientists keep trusting for both safety and performance.
Ultramarine BP EP USP Pharma Grade comes with a legacy. I remember growing up and seeing that signature rich blue shade in a variety of medicines and cosmetics. Behind the color sits a surprising amount of science, trust, and regulation. Ultramarine finds its home in pharmaceuticals largely thanks to its stability, low toxicity, and robust coloring power. The pharma grade variety passes through rigorous testing, usually matching requirements set out in the British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP).
Every tablet or cream with a blue tint doesn't get that way by accident. Coloring in medicine isn’t just for looks. Tablet identification, patient compliance, and product branding all get a boost from recognizable, consistent colors. Ultramarine delivers a bright, stable blue that stands up to light, heat, or the jostle of supply chains. Most importantly, it doesn't react with active ingredients or the body’s chemistry in any concerning way. The FDA and European regulators both treat coloring seriously after decades of learning what can go wrong with impure colors or unsafe alternatives.
Synthetic dyes and other pigments flood the food and pharma market, but Ultramarine stands out because it’s mineral-based. That origin story helps it avoid a lot of the allergic reactions and long-term health questions that hover around some artificial colors. People who work in pharmacy settings point out that Ultramarine does the job without fuss—no weird taste, no extra risk, just a reliable color.
Ultramarine pharma grades go further than pills. I’ve used creams and lotions with its distinctive blue, often in products promoted for soothing or cooling the skin. The pigment holds up just as well in topical formulations. It resists fading under sunlight, making it practical even for products meant to stay visible on the skin.
Every substance put into patient hands comes under scrutiny these days, and Ultramarine isn’t exempt. Sourcing minerals brings up questions around environment and sustainability. Pharmaceutical companies are starting to look for suppliers who guarantee ethical mining and minimal environmental impact. In rare cases, some patients might develop localized reactions to coloring agents, so alternative non-colored drug options stick around for specific needs.
Not all Ultramarine sold in the world meets pharma grade. Some batches get contaminated during extraction or processing, so trustworthy sourcing is essential. Any manufacturer targeting BP, EP, or USP standards commits to batch testing, documentation, and transparency. If there’s a breakdown here, it’s more than just a supplier problem—it’s a health risk. Regulators have responded in the past by tightening labelling rules and requiring oversight at every step.
Looking forward, the industry can strengthen public trust by supporting transparent supply chains and finding better recycling practices for mining waste. Encouraging more research into alternative, safe colors might also give allergic patients even more choice. Color’s importance in medication won’t disappear, but practices around it can improve year by year.
Anyone who’s noticed the bright blue hues in tablets has probably seen ultramarine in action. Ultramarine BP EP USP Pharma Grade stands out as a colorant, giving everything from pills to ointments that unmistakable deep blue color. As a writer who’s spent a lot of time researching ingredient lists and manufacturing processes, I always pay extra attention to substances that go into the things we swallow or apply to our bodies. In medicine, that bright blue isn’t there for fun—it signals a carefully selected additive.
Ultramarine BP EP USP Pharma Grade gets its name from pharmaceutical compendia—British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP). These regulatory bodies keep a sharp eye on purity and safety benchmarks. Only grades that pass these standards make it into pharma products. That’s encouraging, because medicines go through more checks than food or cosmetics.
With ultramarine blue, purity matters. The pharma grade form must be free of heavy metals like lead and arsenic, which could crop up in pigments used in art or construction. There’s chemistry backing this requirement. Regulatory tests look for unwanted elements, and rejected lots never reach medicine manufacturers. I remember walking through an excipient plant in my early reporting days, watching technicians run batch after batch through advanced analyzers, hunting for any sign of contamination before the product moved on.
Reports from regulatory agencies have found that the properly manufactured pharma grade pigment doesn’t break down easily under storage or in the body. It’s considered stable and non-toxic in the amounts approved for medicinal use. Since the 1960s, this pigment has appeared in countless oral and topical medications, with only rare reports of allergic reactions.
No substance deserves blind trust. Quality slips can happen if suppliers cut corners or fake documentation. That’s where traceability comes in. The law requires each lot to be traceable right back to its factory. Pharmacies and drug companies review Certificates of Analysis, sometimes even doing their own lab checks to make sure what’s inside those barrels matches what it says on the tin.
Another issue is overuse. Sticking to approved limits is crucial. Regulators worldwide set maximum levels for colorants to avoid risk. If someone reels off every single medication they use in a day and they all contain ultramarine, the total exposure could get higher than intended. Most people don’t get anywhere near that, but it pays to check.
Drug makers must choose their sources wisely. Skipping out on the cheapest option on the market and demanding audits of their suppliers sets a strong example. Training staff to recognize counterfeit certificates keeps weak links in check. Patients and prescribers benefit when batch results and quality data appear on public databases, not hidden behind paywalls or buried in paperwork.
Blue medicine isn’t new, but it’s always worth questioning what goes into pharmaceuticals. Learning about colorants, demanding ingredient transparency, and taking contamination prevention seriously lead to products people can trust. Medicines only work when trust is built on care, testing, and the humility to keep checking. Ultramarine BP EP USP Pharma Grade doesn’t just make pills pretty—it earns its place by meeting tough checks every step of the way.
Most people recognize ultramarine from the bright blue pigment in art supplies, but in pharmaceuticals, it plays a very different role. Ultramarine blue isn’t just about color—it’s regulated for purity and quality, especially in products taken by mouth. Anyone who’s ever cared about the quality of medicine knows how important it is that every component in a tablet or capsule is both safe and consistent. That’s where pharmaceutical (BP, EP, USP) grades matter.
Pharmaceutical-grade ultramarine fits strict international pharmacopoeia standards—namely BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia). These guidelines draw the line between industrial pigment and material safe for pharmaceutical and food use. True BP/EP/USP grade ultramarine blue comes as a fine powder, almost odorless, and deep blue. The color alone tells you it’s potent, but the specifics are in the testing.
Chemically, it’s sodium alumino sulpho silicate. Good ultramarine will contain at least 95% of this compound by assay. Regulators expect heavy metals like arsenic, cadmium, and mercury to be nearly undetectable—usually less than 10 ppm for lead, 2 ppm for arsenic, and 1 ppm for mercury. Iron content must be below a strict threshold, typically 200 ppm. If you care about what kids or patients ingest, these details mean something.
Good pharmaceutical ultramarine won’t dissolve in water, acids, or alcohol, so it stays stable through the tough process of tablet making. The fine particle size—usually smaller than 20 microns—stops grit and streaking. It should flow well, mix cleanly, and avoid clumping. Any manufacturer ignoring those specs risks ruining a batch of medicine or food.
Pharmacy-grade ultramarine goes through extra washing steps to clean out any sulphides or contaminants. Properly refined material smells clean, not of rotten eggs. I remember touring a plant: Anything less than pure enough for kids’ medicines doesn’t get the pharmaceutical label. Water-soluble substances must test below 1%, and acid-soluble substances are kept just as low.
The color strength gets measured against set standards. One batch should look exactly like the last, and tablets produced on different days need to match. That’s not just for looks—consistency in color means consistency in quality control. Every trustworthy brand I know runs at least half a dozen purity checks on each batch, checking not just color but also particle size and trace residues.
Contamination troubles led to tighter controls. Too much iron, traces of heavy metals, or excess sulphides can endanger patients—especially kids or those with sensitive conditions. Strict pharmacopoeial requirements keep these risks far below levels of concern. Every time I see a GMP-certified batch of ultramarine, I know dozens of checks stood between raw minerals and finished tablets. This makes a real difference for patient safety.
The call for more publicly available batch analysis reports keeps growing. People want to know what’s inside their products, not just accept labels on trust. Where manufacturers share independent lab results, confidence in quality rises—especially in a world full of competing claims. True pharma-grade ultramarine backs up its status with paperwork and transparent testing, not just pretty color.
Ultramarine BP EP USP Pharma Grade comes with clear expectations for quality and purity. Most people would spot this blue pigment in medicines, cosmetics, or even food applications. It never gets old reminding ourselves how even the smallest mistakes in storage can cost a fortune or, worse, pose risks to consumer safety. People tend to underestimate how everyday details matter, such as humidity in a warehouse or the type of materials used alongside the pigment.
Ultramarine in pharma grade form brings a high bar. One minor slip — say, using a rusted metal scoop or a half-sealed container — can lead to failed batches or costly recalls. I once visited a facility where staff handled pigments without gloves. It resulted in cross-contamination that took weeks to sort out and huge losses. The entire batch ended up destroyed. That lesson sticks: use stainless steel tools, and always wear gloves and masks. Pharmaceutical pigments don’t offer second chances.
The blue pigment remains stable only if kept dry and away from heat. Moisture can wreck those vibrant particles, and elevated temperatures start to break down color intensity. In practice, temperature control goes beyond just keeping the thermostat right — the last facility I worked at, people tracked air quality and regularly checked for condensation on storage bins. A simple hygrometer helped catch rising humidity before any major losses. Silica gel packs sometimes offer an extra layer of protection, especially in regions with muggy air.
Once a drum or bag of Ultramarine opens, it must return to an airtight, clearly labeled container. I’ve seen teams cut corners and use bags folded over with tape — then spend days tracking down the cause of a contamination issue. Labels must include the lot number and opening date. Even the act of writing the date in permanent marker stops confusion months later. If everyone in the chain knows exactly what sits inside each container, mistakes drop.
GMP (Good Manufacturing Practice) training can’t feel optional. People need regular refreshers. I remember a young technician assuming the blue pigment could sit out between steps, leading to a whole week of unstable tests. Developing habits — like returning containers immediately after use — keeps things safe and efficient. Managers can’t just set rules; they have to audit storage rooms, quiz staff, and take every concern seriously. Simple checklists work wonders in the daily rush.
Ultramarine chews up acids and reacts to some metallic ions. This doesn’t just ruin pigment performance, it can ruin equipment as well. Never place containers near bleach, acids, or strong oxidizers. Shelves and pallets should be free of any chemical residue. In tighter labs, physical separation or even color-coded shelves help keep things mistake-proof. Coated storage bins prevent accidental contact too.
Shelves off the floor and away from direct sunlight keep things cleaner. In pharma environments, locked cages or designated clean rooms offer better control. Dust covers and periodic cleaning routines minimize risk. Investing in thoughtful storage up front always beats the cost of a ruined batch or failed audit. Avoiding shortcuts keeps end users safe and upholds reputation.
Pharmaceutical manufacturing leaves little room for compromise. The demands of the British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) speak to the need for trust, safety, and reliability in patient care. As someone who has worked alongside pharmacists and regulators, I’ve come to value clear answers on ingredient quality, especially when it involves something as old and widespread as ultramarine pigment.
When a supplier marks ultramarine as BP, EP, or USP compliant, this isn’t just a marketing flourish. BP, EP, and USP sit as three of the world's gold standards for pharmaceutical substances. Each sets strict thresholds for things like heavy metal content, purity, microbiological safety, and solubility. For example, the BP sets the maximum allowable lead limit at 10 ppm, while EP and USP also regulate contaminants tightly. Pharmaceutical grade ultramarine should not carry dangerous levels of heavy metals or any toxic ingredients for that matter.
As trivial as coloring agents may seem, bad batches have caused recalls before. The wrong impurity or a mismanaged process doesn’t just look bad—it can cost lives and trust. A compliant product will give regulators, pharmacists, and patients some peace of mind, knowing every lot stands up to inspection.
Ultramarine’s main job in pharmaceuticals revolves around color correction, mainly in tablets and pills. Usually, it makes products appear consistent and recognizable, which helps both with branding and with identification in the hospital setting. I remember learning about a mixup caused by poorly colored pills, which led to real confusion for both doctors and patients.
The allowable limits for impurities set in the pharmacopeial standards aren’t arbitrary. They come from years of clinical information and documented cases of harm. So, if a supplier claims BP, EP, or USP compliance, they bear the responsibility of providing regular audits, transparent certificates of analysis, and documentation that shows testing was actually done on every batch, not just selected samples.
Getting a substance like ultramarine up to par is expensive and time-consuming. I’ve seen companies cut corners or fudge paperwork, hoping nobody looks too closely. Others might source intermediate materials from regions with less oversight, which opens gaps for contaminants to slip in. It’s not paranoia; traceability scandals make headlines. Genuine compliance—especially ongoing, batch-over-batch—means independent lab testing, open records, and institutional transparency.
On the buying side, pharmacists and formulators have to stay sharp. Certificates alone don’t assure safety. Sometimes it helps to check for third-party accreditation, regular supplier audits, and peer-reviewed data showing actual results, not just promises.
The best safeguard comes from a culture of accountability. Companies that invest in GMP infrastructure, participate in surprise inspections, and welcome audits tend to keep their processes clean. I still recall one QC manager who invited university researchers for parallel testing. Their openness built long-term trust across the supply chain.
To sum it all up, quality standards in pharmaceuticals start long before any pigment enters a pill. Every batch that gets labeled as BP, EP, or USP compliant deserves scrutiny, not just faith. Patients depend on these safeguards, and no reputable firm stakes its reputation lightly.
| Names | |
| Preferred IUPAC name | disodium octasulphate tetradecaisosulphanyloxidoheptaalumododecasilicate |
| Other names |
Ultramarine Blue Pigment Blue 29 CI 77007 Lazurite Sodium aluminosilicate sulfate |
| Pronunciation | /ˌʌltrə.məˈriːn ˌbiːˈpiː ˌiːˈpiː ˌjuːˈɛsˈpiː ˈfɑːrmə ɡreɪd/ |
| Identifiers | |
| CAS Number | 57455-37-5 |
| Beilstein Reference | 1303073 |
| ChEBI | CHEBI:82666 |
| ChEMBL | CHEMBL1201194 |
| ChemSpider | 21566254 |
| DrugBank | DB11097 |
| ECHA InfoCard | echa.infoCard:100.028.315 |
| EC Number | 1302-83-6 |
| Gmelin Reference | 87450 |
| KEGG | C05175 |
| MeSH | D015813 |
| PubChem CID | 16681782 |
| RTECS number | VX8575000 |
| UNII | 3NGB6P7C4R |
| UN number | 3077 |
| CompTox Dashboard (EPA) | DTXSID101086444 |
| Properties | |
| Chemical formula | Na₇Al₆Si₆O₂₄S₃ |
| Molar mass | S = "931.61 g/mol |
| Appearance | Bright blue powder |
| Odor | Odorless |
| Density | 2.40 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | -1.61 |
| Acidity (pKa) | 7–11 |
| Basicity (pKb) | 6.7 |
| Dipole moment | 0.721 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 178 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | V09AA03 |
| Hazards | |
| Main hazards | May cause respiratory irritation. |
| GHS labelling | GHS07, GHS09 |
| Pictograms | GHS07,GHS09 |
| Signal word | Not Classified |
| Hazard statements | No hazard statements. |
| Precautionary statements | Precautionary statements: P264, P270, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | NFPA 704: 1-0-0 |
| LD50 (median dose) | > 10,000 mg/kg (oral, rat) |
| NIOSH | Not Established |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10 mg/d (as per REL, Recommended Exposure Limit) |
| Related compounds | |
| Related compounds |
Pigment Blue 29 Sodium aluminosilicate Ultramarine Pink Ultramarine Violet Ultramarine Green |
Chengguan District, Lanzhou, Gansu, China
